Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations

doi:10.3748/wjg.v26.i17.2040

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7274)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

440

WORD

292

HTML

4225

Figures (1-2)

308

Tables (1-1)

349

Sum=5614

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

788

Download

872

Sum=1660

May 7, 2020 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. May 7, 2020; 26(17): 2040-2048
Published online May 7, 2020. doi: 10.3748/wjg.v26.i17.2040

Full Size Figure Download Figure

Figure 1 Radiofrequency ablation device used to treat hepatocellular carcinoma.

Citation: da Costa AC, Sodergren M, Jayant K, Santa Cruz F, Spalding D, Pai M, Habib N. Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations. World J Gastroenterol 2020; 26(17): 2040-2048
URL: https://www.wjgnet.com/1007-9327/full/v26/i17/2040.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i17.2040